Close Menu

NEW YORK (GenomeWeb) — Co-Diagnostics announced today that its Logix Smart Zika screening test has received CE-IVD marking, permitting its sale in the EU and other areas that recognize the designation.

The PCR-based test is designed to detect the presence or absence of the Zika virus in serum or plasma collected alongside urine from patients with suspected infection. It will be manufactured at the Salt Lake City, Utah-based firm's ISO 13485:2016-certified facility.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Russia says its candidate SARS-CoV-2 vaccine has a very high efficacy rate in an initial analysis of clinical trial data, according to the Financial Times.

Wired reports on a microbial analysis of sketches drawn by Leonardo DaVinci.

A new survey explores coronavirus vaccine hesitancy among Black and Latino individuals, the Washington Post reports.

In Nucleic Acids Research this week: the Aging Atlas database, a database of human metagenome-related metadata, and more.

Dec
01
Sponsored by
Roche

Management of viral infections is critical to prevent severe morbidities and consequences in immune-suppressed transplant patients.

Dec
03
Sponsored by
Mission Bio

Recent work by many investigators has discovered that over the course of aging, hematopoietic stem cells (HSCs) commonly undergo clonal expansion.